Drug profile · INN
dihydroergotamine mesylate
DIHYDROERGOTAMINE MESYLATE
dihydroergotamine mesylate (DIHYDROERGOTAMINE MESYLATE) is a serotonin 1d (5-ht1d) receptor agonist. Associated with Amneal Pharma Europe Ltd. Route of administration: injection. Current US regulatory status: approved.
Drug details — dihydroergotamine mesylate
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.89
Quick answer
dihydroergotamine mesylate (DIHYDROERGOTAMINE MESYLATE) is a serotonin 1d (5-ht1d) receptor agonist. Associated with Amneal Pharma Europe Ltd. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Serotonin 1d (5-HT1d) receptor agonist
Primary target: 5-hydroxytryptamine receptor 1D
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is dihydroergotamine mesylate?
dihydroergotamine mesylate (DIHYDROERGOTAMINE MESYLATE) is a serotonin 1d (5-ht1d) receptor agonist. Associated with Amneal Pharma Europe Ltd. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for dihydroergotamine mesylate?
DIHYDROERGOTAMINE MESYLATE is a marketed brand name for dihydroergotamine mesylate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of dihydroergotamine mesylate?
dihydroergotamine mesylate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.